Hattiesburg Clinic | Hematology/Oncology Department

Research site

(Unclaimed)

Location

301 S. 28th Avenue, Hattiesburg, Mississippi, United States of America

Site insights

Top conditions

Top treatments

Pembrolizumab

Platinum

Dexamethasone

ABBV-400

MK-1084

MK-6482

Trifluridine

Leucovorin

Cisplatin

Fluorouracil

Parent organization

This site is a part of Hattiesburg Clinic

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 12 total trials

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation...

Enrolling

Rectal Adenocarcinoma

Colon Adenocarcinoma

Drug: Leucovorin/levofolinate calcium

Drug: 5-Fluorouracil

A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer

Colorectal cancer (CRC) is the third most common type of cancer diagnosed worldwide and in China. The purpose of this study is to assess adverse even...

Enrolling

Metastatic Colorectal Cancer

Drug: Trifluridine/Tipiracil

Drug: Telisotuzumab Adizutecan

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

The primary objective of this study is to compare belzutifan to everolimus with respect to progression-free survival (PFS) per Response Evaluation Cr...

Active, not recruiting

Carcinoma, Renal Cell

Drug: Everolimus

Drug: Belzutifan

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (AndroMETa-GEA)

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events...

Enrolling

Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma

Esophageal Adenocarcinoma

Drug: Budigalimab

Drug: Oxaliplatin

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM (IRAKLIA)

This is a randomized, multicenter, Phase 3, open-label study evaluating subcutaneous (SC) vs intravenous (IV) administration of isatuximab in combina...

Active, not recruiting

Plasma Cell Myeloma Recurrent

Drug: Montelukast

Drug: Dexamethasone

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL) (ReVenG)

Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess retreatment with venet...

Enrolling

Chronic Lymphocytic Leukemia (CLL)

Drug: Venetoclax

Drug: Obinutuzumab

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms